KOZARICH JOHN W — SEC insider filings

SEC reporting owner CIK 1223000. 26 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2021-02-23 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LIGAND PHARMACEUTICALS INC (LGND)Director26—53 legs · 19,898 sh · $2,539,14930

Insider filings — KOZARICH JOHN W

FiledFormIssuerReported transactionsSource
2026-11-164LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 500 @ $325EDGAR
2026-06-094LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 836 @ $0 · Grant/award (A): 2,938 (derivative) @ $0EDGAR
2026-05-144LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 80 @ $227.37 · Sale (S): 1 @ $229.87 · Sale (S): 165 @ $231.87 · Sale (S): 105 @ $232.57 · Sale (S): 116 @ $234.09 · Option exercise (M): 459 @ $69.51 · +5 moreEDGAR
2026-04-024LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 146 @ $199.97 · Sale (S): 40 @ $201.24 · Sale (S): 79 @ $202.42 · Sale (S): 43 @ $202.91 · Sale (S): 159 @ $204.26EDGAR
2026-03-044LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 47 @ $197.14 · Sale (S): 204 @ $199.69 · Sale (S): 41 @ $200.40 · Sale (S): 83 @ $201.65 · Sale (S): 50 @ $202.54 · Sale (S): 42 @ $203.57EDGAR
2026-02-044LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 39 @ $191 · Sale (S): 1 @ $192.18 · Sale (S): 23 @ $195.60 · Sale (S): 381 @ $196.36 · Sale (S): 23 @ $197.19EDGAR
2026-01-064LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 21 @ $186.59 · Sale (S): 91 @ $187.95 · Sale (S): 102 @ $188.96 · Sale (S): 207 @ $190.27 · Sale (S): 46 @ $192.40EDGAR
2025-12-034LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 92 @ $193.86 · Sale (S): 179 @ $194.76 · Sale (S): 47 @ $195.80 · Sale (S): 4 @ $196.34 · Sale (S): 92 @ $197.72 · Sale (S): 23 @ $199.22 · +1 moreEDGAR
2025-11-054LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 84 @ $189.00 · Sale (S): 49 @ $190.26 · Sale (S): 207 @ $191.25 · Sale (S): 127 @ $192.38EDGAR
2025-10-034LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 24 @ $177.60 · Sale (S): 196 @ $178.41 · Sale (S): 155 @ $180.01 · Sale (S): 92 @ $181.18EDGAR
2025-09-044LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 267 @ $161.51 · Sale (S): 115 @ $162.52 · Sale (S): 85 @ $164.25EDGAR
2025-08-054LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 467 @ $131.88EDGAR
2025-07-114LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 934 @ $125EDGAR
2025-06-104LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,209 @ $0 · Grant/award (A): 5,783 (derivative) @ $0EDGAR
2025-06-024LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,406 @ $52.30 · Option exercise (M): 2,406 (derivative) @ $0EDGAR
2024-06-184LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,252 @ $0 · Grant/award (A): 5,444 (derivative) @ $0EDGAR
2024-04-264LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,893 @ $39.35 · Option exercise (M): 2,893 (derivative) @ $0EDGAR
2023-06-134LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,142 @ $0 · Grant/award (A): 5,461 (derivative) @ $0EDGAR
2023-05-184LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 4,444 @ $77.20EDGAR
2023-05-104LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 6,408 @ $18.82 · Sale (S): 5,819 @ $76.51 · Sale (S): 589 @ $77.10 · Option exercise (M): 6,408 (derivative) @ $0EDGAR
2022-12-274LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 6,623 (derivative) @ $0EDGAR
2022-06-134LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,004 @ $0 · Grant/award (A): 4,340 (derivative) @ $0EDGAR
2022-03-014LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 7,335 @ $12.53 · Sale (S): 908 @ $102.62 · Option exercise (M): 7,335 (derivative) @ $0EDGAR
2021-06-074LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 630 @ $0 · Grant/award (A): 3,269 (derivative) @ $0EDGAR
2021-05-134LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 4,835 @ $10.12 · Tax withholding (F): 391 @ $128.56 · Option exercise (M): 4,835 (derivative) @ $0EDGAR
2021-02-234LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,500 @ $10.12 · Option exercise (M): 2,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1223000 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs